nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—breast cancer	0.186	0.34	CiPCiCtD
Nelarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—breast cancer	0.186	0.34	CiPCiCtD
Nelarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—breast cancer	0.175	0.32	CiPCiCtD
Nelarabine—POLA1—Gemcitabine—breast cancer	0.0915	0.619	CbGbCtD
Nelarabine—DCK—Gemcitabine—breast cancer	0.0563	0.381	CbGbCtD
Nelarabine—Cytarabine—Gemcitabine—breast cancer	0.053	0.35	CrCrCtD
Nelarabine—Azacitidine—Gemcitabine—breast cancer	0.0503	0.333	CrCrCtD
Nelarabine—Decitabine—Gemcitabine—breast cancer	0.0479	0.317	CrCrCtD
Nelarabine—DGUOK—mammary gland—breast cancer	0.00213	0.0861	CbGeAlD
Nelarabine—DGUOK—nipple—breast cancer	0.00176	0.0712	CbGeAlD
Nelarabine—POLA1—mammary gland—breast cancer	0.00131	0.0531	CbGeAlD
Nelarabine—DGUOK—endometrium—breast cancer	0.00106	0.043	CbGeAlD
Nelarabine—DGUOK—uterus—breast cancer	0.00098	0.0396	CbGeAlD
Nelarabine—DGUOK—pituitary gland—breast cancer	0.000963	0.0389	CbGeAlD
Nelarabine—DGUOK—adipose tissue—breast cancer	0.000959	0.0388	CbGeAlD
Nelarabine—DGUOK—female reproductive system—breast cancer	0.000881	0.0356	CbGeAlD
Nelarabine—DGUOK—adrenal gland—breast cancer	0.00086	0.0348	CbGeAlD
Nelarabine—DGUOK—bone marrow—breast cancer	0.000832	0.0336	CbGeAlD
Nelarabine—DGUOK—female gonad—breast cancer	0.000802	0.0324	CbGeAlD
Nelarabine—DGUOK—endocrine gland—breast cancer	0.000746	0.0301	CbGeAlD
Nelarabine—DCK—nipple—breast cancer	0.00067	0.0271	CbGeAlD
Nelarabine—POLA1—endometrium—breast cancer	0.000656	0.0265	CbGeAlD
Nelarabine—POLA1—pituitary gland—breast cancer	0.000594	0.024	CbGeAlD
Nelarabine—POLA1—adipose tissue—breast cancer	0.000591	0.0239	CbGeAlD
Nelarabine—DCK—embryo—breast cancer	0.000553	0.0223	CbGeAlD
Nelarabine—ADA—adipose tissue—breast cancer	0.000549	0.0222	CbGeAlD
Nelarabine—POLA1—adrenal gland—breast cancer	0.000531	0.0214	CbGeAlD
Nelarabine—DGUOK—lymph node—breast cancer	0.000516	0.0208	CbGeAlD
Nelarabine—POLA1—bone marrow—breast cancer	0.000513	0.0207	CbGeAlD
Nelarabine—ADA—female reproductive system—breast cancer	0.000504	0.0204	CbGeAlD
Nelarabine—POLA1—female gonad—breast cancer	0.000495	0.02	CbGeAlD
Nelarabine—ADA—adrenal gland—breast cancer	0.000492	0.0199	CbGeAlD
Nelarabine—ADA—bone marrow—breast cancer	0.000476	0.0192	CbGeAlD
Nelarabine—ADA—endocrine gland—breast cancer	0.000427	0.0172	CbGeAlD
Nelarabine—DCK—endometrium—breast cancer	0.000405	0.0164	CbGeAlD
Nelarabine—DCK—uterus—breast cancer	0.000373	0.0151	CbGeAlD
Nelarabine—DCK—pituitary gland—breast cancer	0.000366	0.0148	CbGeAlD
Nelarabine—DCK—adipose tissue—breast cancer	0.000365	0.0147	CbGeAlD
Nelarabine—DCK—female reproductive system—breast cancer	0.000335	0.0135	CbGeAlD
Nelarabine—DCK—adrenal gland—breast cancer	0.000327	0.0132	CbGeAlD
Nelarabine—POLA1—lymph node—breast cancer	0.000318	0.0129	CbGeAlD
Nelarabine—DCK—bone marrow—breast cancer	0.000316	0.0128	CbGeAlD
Nelarabine—DCK—female gonad—breast cancer	0.000305	0.0123	CbGeAlD
Nelarabine—ADA—lymph node—breast cancer	0.000295	0.0119	CbGeAlD
Nelarabine—DCK—endocrine gland—breast cancer	0.000284	0.0115	CbGeAlD
Nelarabine—DCK—Topotecan—Irinotecan—breast cancer	0.000278	0.199	CbGdCrCtD
Nelarabine—Azacitidine—DNMT3A—breast cancer	0.000277	0.111	CrCbGaD
Nelarabine—Decitabine—DNMT3A—breast cancer	0.00027	0.108	CrCbGaD
Nelarabine—POLA1—Vinblastine—Vinorelbine—breast cancer	0.000261	0.188	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ARAF—breast cancer	0.000253	0.101	CrCbGaD
Nelarabine—Azacitidine—CDA—breast cancer	0.000247	0.0989	CrCbGaD
Nelarabine—DCK—lymph node—breast cancer	0.000196	0.00792	CbGeAlD
Nelarabine—Adenosine monophosphate—PIM1—breast cancer	0.000168	0.0672	CrCbGaD
Nelarabine—Azacitidine—DNMT1—breast cancer	0.00015	0.0599	CrCbGaD
Nelarabine—Decitabine—DNMT1—breast cancer	0.000146	0.0585	CrCbGaD
Nelarabine—Adenosine triphosphate—HSPA1B—breast cancer	0.000146	0.0583	CrCbGaD
Nelarabine—Adenosine monophosphate—APRT—breast cancer	0.000143	0.0572	CrCbGaD
Nelarabine—POLA1—Norethindrone—Fluoxymesterone—breast cancer	0.000143	0.102	CbGdCrCtD
Nelarabine—DCK—Epirubicin—Idarubicin—breast cancer	0.000142	0.102	CbGdCrCtD
Nelarabine—DCK—Doxorubicin—Idarubicin—breast cancer	0.000142	0.102	CbGdCrCtD
Nelarabine—Cytarabine—CDA—breast cancer	0.000141	0.0565	CrCbGaD
Nelarabine—DCK—Clomifene—Toremifene—breast cancer	0.000136	0.0977	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ACVR1—breast cancer	0.000124	0.0496	CrCbGaD
Nelarabine—DCK—Clomifene—Tamoxifen—breast cancer	8.55e-05	0.0614	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Fluoxymesterone—breast cancer	8e-05	0.0574	CbGdCrCtD
Nelarabine—Adenosine triphosphate—ALK—breast cancer	6.68e-05	0.0268	CrCbGaD
Nelarabine—DCK—Doxorubicin—Epirubicin—breast cancer	6.53e-05	0.0469	CbGdCrCtD
Nelarabine—S-Adenosylmethionine—COMT—breast cancer	6.04e-05	0.0242	CrCbGaD
Nelarabine—DCK—Epirubicin—Doxorubicin—breast cancer	6.04e-05	0.0434	CbGdCrCtD
Nelarabine—Adenosine monophosphate—PDE4D—breast cancer	5.88e-05	0.0236	CrCbGaD
Nelarabine—Adenosine triphosphate—AKT1—breast cancer	5.22e-05	0.0209	CrCbGaD
Nelarabine—Adenosine monophosphate—SRC—breast cancer	5.14e-05	0.0206	CrCbGaD
Nelarabine—Adenosine triphosphate—ABL1—breast cancer	4.93e-05	0.0197	CrCbGaD
Nelarabine—Clofarabine—ABCG2—breast cancer	4.48e-05	0.018	CrCbGaD
Nelarabine—Cladribine—ABCG2—breast cancer	2.57e-05	0.0103	CrCbGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	1.95e-05	0.00042	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALDH1A1—breast cancer	1.93e-05	0.000416	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALDH7A1—breast cancer	1.93e-05	0.000416	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	1.93e-05	0.000415	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—MTHFR—breast cancer	1.93e-05	0.000415	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—RAD51—breast cancer	1.92e-05	0.000413	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CCND1—breast cancer	1.9e-05	0.00041	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—JUN—breast cancer	1.9e-05	0.000409	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—TOP2A—breast cancer	1.87e-05	0.000403	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HADHB—breast cancer	1.87e-05	0.000403	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPI—breast cancer	1.87e-05	0.000403	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PHGDH—breast cancer	1.85e-05	0.000399	CbGpPWpGaD
Nelarabine—ADA—Metabolism—UMPS—breast cancer	1.85e-05	0.000399	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ADSL—breast cancer	1.85e-05	0.000399	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FHL2—breast cancer	1.85e-05	0.000399	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NME1—breast cancer	1.85e-05	0.000399	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—breast cancer	1.85e-05	0.000399	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CDKN1A—breast cancer	1.84e-05	0.000396	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PTEN—breast cancer	1.84e-05	0.000395	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	1.82e-05	0.000391	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BRIP1—breast cancer	1.82e-05	0.000391	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LDHB—breast cancer	1.82e-05	0.000391	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HPSE—breast cancer	1.82e-05	0.000391	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—MAPK8—breast cancer	1.8e-05	0.000387	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	1.79e-05	0.000385	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—AURKA—breast cancer	1.79e-05	0.000384	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALDH1A1—breast cancer	1.78e-05	0.000384	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALDH7A1—breast cancer	1.78e-05	0.000384	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CAV1—breast cancer	1.78e-05	0.000383	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—NBN—breast cancer	1.78e-05	0.000382	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCND1—breast cancer	1.77e-05	0.00038	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMMR—breast cancer	1.72e-05	0.000371	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCC1—breast cancer	1.72e-05	0.000371	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA3—breast cancer	1.72e-05	0.000371	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ADSL—breast cancer	1.71e-05	0.000368	CbGpPWpGaD
Nelarabine—DCK—Metabolism—UMPS—breast cancer	1.71e-05	0.000368	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FHL2—breast cancer	1.71e-05	0.000368	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NME1—breast cancer	1.71e-05	0.000368	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PHGDH—breast cancer	1.71e-05	0.000368	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—breast cancer	1.71e-05	0.000368	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—MYC—breast cancer	1.68e-05	0.000362	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HPSE—breast cancer	1.68e-05	0.000361	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LDHB—breast cancer	1.68e-05	0.000361	CbGpPWpGaD
Nelarabine—DCK—Metabolism—BRIP1—breast cancer	1.68e-05	0.000361	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TOP2A—breast cancer	1.67e-05	0.00036	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARGC1B—breast cancer	1.67e-05	0.000359	CbGpPWpGaD
Nelarabine—Cough—Capecitabine—breast cancer	1.66e-05	0.000211	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—H2AFX—breast cancer	1.66e-05	0.000357	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—breast cancer	1.65e-05	0.000356	CbGpPWpGaD
Nelarabine—Stomatitis—Epirubicin—breast cancer	1.65e-05	0.00021	CcSEcCtD
Nelarabine—Neutropenia—Doxorubicin—breast cancer	1.65e-05	0.000209	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—E2F1—breast cancer	1.65e-05	0.000354	CbGpPWpGaD
Nelarabine—Decreased appetite—Paclitaxel—breast cancer	1.65e-05	0.000209	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Paclitaxel—breast cancer	1.63e-05	0.000207	CcSEcCtD
Nelarabine—Fatigue—Paclitaxel—breast cancer	1.63e-05	0.000207	CcSEcCtD
Nelarabine—Asthenia—Gemcitabine—breast cancer	1.62e-05	0.000206	CcSEcCtD
Nelarabine—Myalgia—Capecitabine—breast cancer	1.62e-05	0.000206	CcSEcCtD
Nelarabine—Arthralgia—Capecitabine—breast cancer	1.62e-05	0.000206	CcSEcCtD
Nelarabine—Chest pain—Capecitabine—breast cancer	1.62e-05	0.000206	CcSEcCtD
Nelarabine—Constipation—Paclitaxel—breast cancer	1.62e-05	0.000205	CcSEcCtD
Nelarabine—Pain—Paclitaxel—breast cancer	1.62e-05	0.000205	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CG—breast cancer	1.62e-05	0.000348	CbGpPWpGaD
Nelarabine—Confusional state—Docetaxel—breast cancer	1.62e-05	0.000205	CcSEcCtD
Nelarabine—Urinary tract disorder—Methotrexate—breast cancer	1.61e-05	0.000204	CcSEcCtD
Nelarabine—Hepatobiliary disease—Epirubicin—breast cancer	1.61e-05	0.000204	CcSEcCtD
Nelarabine—Oedema—Docetaxel—breast cancer	1.6e-05	0.000204	CcSEcCtD
Nelarabine—Epistaxis—Epirubicin—breast cancer	1.6e-05	0.000203	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—AURKA—breast cancer	1.6e-05	0.000344	CbGpPWpGaD
Nelarabine—Nausea—Thiotepa—breast cancer	1.6e-05	0.000203	CcSEcCtD
Nelarabine—Urethral disorder—Methotrexate—breast cancer	1.6e-05	0.000203	CcSEcCtD
Nelarabine—Infection—Docetaxel—breast cancer	1.59e-05	0.000202	CcSEcCtD
Nelarabine—Sinusitis—Epirubicin—breast cancer	1.59e-05	0.000202	CcSEcCtD
Nelarabine—DCK—Metabolism—HMMR—breast cancer	1.59e-05	0.000342	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTA3—breast cancer	1.59e-05	0.000342	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCC1—breast cancer	1.59e-05	0.000342	CbGpPWpGaD
Nelarabine—Hyperglycaemia—Doxorubicin—breast cancer	1.59e-05	0.000202	CcSEcCtD
Nelarabine—Diarrhoea—Mitoxantrone—breast cancer	1.59e-05	0.000202	CcSEcCtD
Nelarabine—Diarrhoea—Irinotecan—breast cancer	1.59e-05	0.000202	CcSEcCtD
Nelarabine—Pneumonia—Doxorubicin—breast cancer	1.58e-05	0.0002	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTA4—breast cancer	1.58e-05	0.000339	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CA9—breast cancer	1.58e-05	0.000339	CbGpPWpGaD
Nelarabine—Nervous system disorder—Docetaxel—breast cancer	1.57e-05	0.0002	CcSEcCtD
Nelarabine—Thrombocytopenia—Docetaxel—breast cancer	1.57e-05	0.000199	CcSEcCtD
Nelarabine—Infestation NOS—Doxorubicin—breast cancer	1.57e-05	0.000199	CcSEcCtD
Nelarabine—Infestation—Doxorubicin—breast cancer	1.57e-05	0.000199	CcSEcCtD
Nelarabine—Confusional state—Capecitabine—breast cancer	1.57e-05	0.000199	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—HSP90AA1—breast cancer	1.56e-05	0.000336	CbGpPWpGaD
Nelarabine—Feeling abnormal—Paclitaxel—breast cancer	1.56e-05	0.000198	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	1.56e-05	0.000336	CbGpPWpGaD
Nelarabine—Oedema—Capecitabine—breast cancer	1.55e-05	0.000197	CcSEcCtD
Nelarabine—Gastrointestinal pain—Paclitaxel—breast cancer	1.55e-05	0.000196	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—breast cancer	1.55e-05	0.000333	CbGpPWpGaD
Nelarabine—Diarrhoea—Gemcitabine—breast cancer	1.55e-05	0.000196	CcSEcCtD
Nelarabine—Infection—Capecitabine—breast cancer	1.54e-05	0.000196	CcSEcCtD
Nelarabine—DCK—Metabolism—PPARGC1B—breast cancer	1.54e-05	0.000332	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Doxorubicin—breast cancer	1.54e-05	0.000195	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	1.54e-05	0.000331	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPX2—breast cancer	1.54e-05	0.000331	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA2—breast cancer	1.54e-05	0.000331	CbGpPWpGaD
Nelarabine—Dizziness—Irinotecan—breast cancer	1.54e-05	0.000195	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.53e-05	0.00033	CbGpPWpGaD
Nelarabine—Stomatitis—Doxorubicin—breast cancer	1.53e-05	0.000194	CcSEcCtD
Nelarabine—Anorexia—Docetaxel—breast cancer	1.53e-05	0.000194	CcSEcCtD
Nelarabine—POLA1—S Phase—MYC—breast cancer	1.53e-05	0.000329	CbGpPWpGaD
Nelarabine—Nervous system disorder—Capecitabine—breast cancer	1.52e-05	0.000193	CcSEcCtD
Nelarabine—Eye disorder—Methotrexate—breast cancer	1.52e-05	0.000193	CcSEcCtD
Nelarabine—Diarrhoea—Fluorouracil—breast cancer	1.52e-05	0.000193	CcSEcCtD
Nelarabine—Thrombocytopenia—Capecitabine—breast cancer	1.52e-05	0.000193	CcSEcCtD
Nelarabine—ADA—Metabolism—GPX4—breast cancer	1.52e-05	0.000327	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SULT1A1—breast cancer	1.52e-05	0.000327	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Epirubicin—breast cancer	1.52e-05	0.000192	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.52e-05	0.000326	CbGpPWpGaD
Nelarabine—Cardiac disorder—Methotrexate—breast cancer	1.51e-05	0.000192	CcSEcCtD
Nelarabine—Urinary tract disorder—Epirubicin—breast cancer	1.5e-05	0.000191	CcSEcCtD
Nelarabine—Oedema peripheral—Epirubicin—breast cancer	1.5e-05	0.00019	CcSEcCtD
Nelarabine—Hypotension—Docetaxel—breast cancer	1.5e-05	0.00019	CcSEcCtD
Nelarabine—Connective tissue disorder—Epirubicin—breast cancer	1.5e-05	0.00019	CcSEcCtD
Nelarabine—Abdominal pain—Paclitaxel—breast cancer	1.5e-05	0.00019	CcSEcCtD
Nelarabine—Body temperature increased—Paclitaxel—breast cancer	1.5e-05	0.00019	CcSEcCtD
Nelarabine—Urethral disorder—Epirubicin—breast cancer	1.49e-05	0.00019	CcSEcCtD
Nelarabine—Hepatobiliary disease—Doxorubicin—breast cancer	1.49e-05	0.000188	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.48e-05	0.000319	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA1—breast cancer	1.48e-05	0.000319	CbGpPWpGaD
Nelarabine—ADA—Metabolism—IDH1—breast cancer	1.48e-05	0.000319	CbGpPWpGaD
Nelarabine—Epistaxis—Doxorubicin—breast cancer	1.48e-05	0.000188	CcSEcCtD
Nelarabine—Anorexia—Capecitabine—breast cancer	1.48e-05	0.000188	CcSEcCtD
Nelarabine—Angiopathy—Methotrexate—breast cancer	1.48e-05	0.000187	CcSEcCtD
Nelarabine—Vomiting—Mitoxantrone—breast cancer	1.48e-05	0.000187	CcSEcCtD
Nelarabine—Vomiting—Irinotecan—breast cancer	1.48e-05	0.000187	CcSEcCtD
Nelarabine—Sinusitis—Doxorubicin—breast cancer	1.47e-05	0.000187	CcSEcCtD
Nelarabine—Dizziness—Fluorouracil—breast cancer	1.47e-05	0.000187	CcSEcCtD
Nelarabine—Mediastinal disorder—Methotrexate—breast cancer	1.47e-05	0.000186	CcSEcCtD
Nelarabine—ADA—Metabolism—NAT2—breast cancer	1.47e-05	0.000315	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Docetaxel—breast cancer	1.46e-05	0.000186	CcSEcCtD
Nelarabine—Chills—Methotrexate—breast cancer	1.46e-05	0.000185	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTA4—breast cancer	1.45e-05	0.000313	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CA9—breast cancer	1.45e-05	0.000313	CbGpPWpGaD
Nelarabine—Headache—Mitoxantrone—breast cancer	1.45e-05	0.000185	CcSEcCtD
Nelarabine—Headache—Irinotecan—breast cancer	1.45e-05	0.000185	CcSEcCtD
Nelarabine—Hypotension—Capecitabine—breast cancer	1.45e-05	0.000184	CcSEcCtD
Nelarabine—Insomnia—Docetaxel—breast cancer	1.45e-05	0.000184	CcSEcCtD
Nelarabine—Paraesthesia—Docetaxel—breast cancer	1.44e-05	0.000183	CcSEcCtD
Nelarabine—Vomiting—Gemcitabine—breast cancer	1.44e-05	0.000182	CcSEcCtD
Nelarabine—Dyspnoea—Docetaxel—breast cancer	1.43e-05	0.000182	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CHEK2—breast cancer	1.43e-05	0.000307	CbGpPWpGaD
Nelarabine—Somnolence—Docetaxel—breast cancer	1.43e-05	0.000181	CcSEcCtD
Nelarabine—Mental disorder—Methotrexate—breast cancer	1.43e-05	0.000181	CcSEcCtD
Nelarabine—Eye disorder—Epirubicin—breast cancer	1.42e-05	0.000181	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CD—breast cancer	1.42e-05	0.000306	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—CDK2—breast cancer	1.42e-05	0.000306	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—breast cancer	1.42e-05	0.000305	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTA2—breast cancer	1.42e-05	0.000305	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPX2—breast cancer	1.42e-05	0.000305	CbGpPWpGaD
Nelarabine—Malnutrition—Methotrexate—breast cancer	1.42e-05	0.00018	CcSEcCtD
Nelarabine—Headache—Gemcitabine—breast cancer	1.42e-05	0.00018	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Capecitabine—breast cancer	1.42e-05	0.00018	CcSEcCtD
Nelarabine—Cardiac disorder—Epirubicin—breast cancer	1.41e-05	0.000179	CcSEcCtD
Nelarabine—Vomiting—Fluorouracil—breast cancer	1.41e-05	0.000179	CcSEcCtD
Nelarabine—Insomnia—Capecitabine—breast cancer	1.41e-05	0.000178	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ALB—breast cancer	1.4e-05	0.000302	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.4e-05	0.000302	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Doxorubicin—breast cancer	1.4e-05	0.000178	CcSEcCtD
Nelarabine—DCK—Metabolism—SULT1A1—breast cancer	1.4e-05	0.000301	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPX4—breast cancer	1.4e-05	0.000301	CbGpPWpGaD
Nelarabine—Cytarabine—CYP3A4—breast cancer	1.4e-05	0.0056	CrCbGaD
Nelarabine—POLA1—Cell Cycle—HSP90AA1—breast cancer	1.4e-05	0.0003	CbGpPWpGaD
Nelarabine—Paraesthesia—Capecitabine—breast cancer	1.4e-05	0.000177	CcSEcCtD
Nelarabine—Decreased appetite—Docetaxel—breast cancer	1.4e-05	0.000177	CcSEcCtD
Nelarabine—Headache—Fluorouracil—breast cancer	1.39e-05	0.000177	CcSEcCtD
Nelarabine—Urinary tract disorder—Doxorubicin—breast cancer	1.39e-05	0.000177	CcSEcCtD
Nelarabine—Oedema peripheral—Doxorubicin—breast cancer	1.39e-05	0.000176	CcSEcCtD
Nelarabine—Dysgeusia—Methotrexate—breast cancer	1.39e-05	0.000176	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Docetaxel—breast cancer	1.39e-05	0.000176	CcSEcCtD
Nelarabine—Connective tissue disorder—Doxorubicin—breast cancer	1.39e-05	0.000176	CcSEcCtD
Nelarabine—Dyspnoea—Capecitabine—breast cancer	1.39e-05	0.000176	CcSEcCtD
Nelarabine—Fatigue—Docetaxel—breast cancer	1.38e-05	0.000176	CcSEcCtD
Nelarabine—Angiopathy—Epirubicin—breast cancer	1.38e-05	0.000175	CcSEcCtD
Nelarabine—Urethral disorder—Doxorubicin—breast cancer	1.38e-05	0.000175	CcSEcCtD
Nelarabine—Nausea—Mitoxantrone—breast cancer	1.38e-05	0.000175	CcSEcCtD
Nelarabine—Nausea—Irinotecan—breast cancer	1.38e-05	0.000175	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.38e-05	0.000296	CbGpPWpGaD
Nelarabine—Mediastinal disorder—Epirubicin—breast cancer	1.37e-05	0.000174	CcSEcCtD
Nelarabine—Constipation—Docetaxel—breast cancer	1.37e-05	0.000174	CcSEcCtD
Nelarabine—Pain—Docetaxel—breast cancer	1.37e-05	0.000174	CcSEcCtD
Nelarabine—Back pain—Methotrexate—breast cancer	1.37e-05	0.000174	CcSEcCtD
Nelarabine—DCK—Metabolism—IDH1—breast cancer	1.37e-05	0.000294	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTA1—breast cancer	1.37e-05	0.000294	CbGpPWpGaD
Nelarabine—Chills—Epirubicin—breast cancer	1.37e-05	0.000173	CcSEcCtD
Nelarabine—Asthenia—Paclitaxel—breast cancer	1.36e-05	0.000172	CcSEcCtD
Nelarabine—DCK—Metabolism—NAT2—breast cancer	1.35e-05	0.000291	CbGpPWpGaD
Nelarabine—Decreased appetite—Capecitabine—breast cancer	1.35e-05	0.000171	CcSEcCtD
Nelarabine—DGUOK—Metabolism—NOS3—breast cancer	1.34e-05	0.000289	CbGpPWpGaD
Nelarabine—Nausea—Gemcitabine—breast cancer	1.34e-05	0.00017	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Capecitabine—breast cancer	1.34e-05	0.00017	CcSEcCtD
Nelarabine—Fatigue—Capecitabine—breast cancer	1.34e-05	0.00017	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.34e-05	0.000288	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—BRCA1—breast cancer	1.34e-05	0.000288	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.34e-05	0.000288	CbGpPWpGaD
Nelarabine—Vision blurred—Methotrexate—breast cancer	1.34e-05	0.00017	CcSEcCtD
Nelarabine—Mental disorder—Epirubicin—breast cancer	1.33e-05	0.000169	CcSEcCtD
Nelarabine—Pain—Capecitabine—breast cancer	1.33e-05	0.000169	CcSEcCtD
Nelarabine—Constipation—Capecitabine—breast cancer	1.33e-05	0.000169	CcSEcCtD
Nelarabine—Malnutrition—Epirubicin—breast cancer	1.33e-05	0.000168	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.33e-05	0.000285	CbGpPWpGaD
Nelarabine—Feeling abnormal—Docetaxel—breast cancer	1.32e-05	0.000168	CcSEcCtD
Nelarabine—Nausea—Fluorouracil—breast cancer	1.32e-05	0.000168	CcSEcCtD
Nelarabine—Eye disorder—Doxorubicin—breast cancer	1.32e-05	0.000167	CcSEcCtD
Nelarabine—Gastrointestinal pain—Docetaxel—breast cancer	1.31e-05	0.000167	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCNE1—breast cancer	1.31e-05	0.000282	CbGpPWpGaD
Nelarabine—Anaemia—Methotrexate—breast cancer	1.31e-05	0.000166	CcSEcCtD
Nelarabine—Cardiac disorder—Doxorubicin—breast cancer	1.31e-05	0.000166	CcSEcCtD
Nelarabine—Dysgeusia—Epirubicin—breast cancer	1.3e-05	0.000165	CcSEcCtD
Nelarabine—Diarrhoea—Paclitaxel—breast cancer	1.3e-05	0.000164	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.3e-05	0.000279	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.29e-05	0.000278	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—TYMS—breast cancer	1.29e-05	0.000277	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MED12—breast cancer	1.29e-05	0.000277	CbGpPWpGaD
Nelarabine—ADA—Metabolism—DPYD—breast cancer	1.29e-05	0.000277	CbGpPWpGaD
Nelarabine—Back pain—Epirubicin—breast cancer	1.28e-05	0.000163	CcSEcCtD
Nelarabine—Feeling abnormal—Capecitabine—breast cancer	1.28e-05	0.000162	CcSEcCtD
Nelarabine—Angiopathy—Doxorubicin—breast cancer	1.28e-05	0.000162	CcSEcCtD
Nelarabine—Gastrointestinal pain—Capecitabine—breast cancer	1.27e-05	0.000161	CcSEcCtD
Nelarabine—Mediastinal disorder—Doxorubicin—breast cancer	1.27e-05	0.000161	CcSEcCtD
Nelarabine—Body temperature increased—Docetaxel—breast cancer	1.27e-05	0.000161	CcSEcCtD
Nelarabine—Abdominal pain—Docetaxel—breast cancer	1.27e-05	0.000161	CcSEcCtD
Nelarabine—Leukopenia—Methotrexate—breast cancer	1.27e-05	0.000161	CcSEcCtD
Nelarabine—Chills—Doxorubicin—breast cancer	1.27e-05	0.000161	CcSEcCtD
Nelarabine—ADA—Metabolism—ALDOA—breast cancer	1.27e-05	0.000272	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.26e-05	0.000272	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TP53—breast cancer	1.25e-05	0.00027	CbGpPWpGaD
Nelarabine—Dizziness—Paclitaxel—breast cancer	1.25e-05	0.000159	CcSEcCtD
Nelarabine—Vision blurred—Epirubicin—breast cancer	1.25e-05	0.000159	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CB—breast cancer	1.24e-05	0.000267	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—H2AFX—breast cancer	1.24e-05	0.000267	CbGpPWpGaD
Nelarabine—Cough—Methotrexate—breast cancer	1.24e-05	0.000157	CcSEcCtD
Nelarabine—Mental disorder—Doxorubicin—breast cancer	1.24e-05	0.000157	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—E2F1—breast cancer	1.23e-05	0.000265	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS2—breast cancer	1.23e-05	0.000265	CbGpPWpGaD
Nelarabine—Body temperature increased—Capecitabine—breast cancer	1.23e-05	0.000156	CcSEcCtD
Nelarabine—Abdominal pain—Capecitabine—breast cancer	1.23e-05	0.000156	CcSEcCtD
Nelarabine—ADA—Metabolism—NCOA3—breast cancer	1.23e-05	0.000264	CbGpPWpGaD
Nelarabine—Convulsion—Methotrexate—breast cancer	1.23e-05	0.000156	CcSEcCtD
Nelarabine—Malnutrition—Doxorubicin—breast cancer	1.23e-05	0.000156	CcSEcCtD
Nelarabine—Anaemia—Epirubicin—breast cancer	1.23e-05	0.000156	CcSEcCtD
Nelarabine—ADA—Metabolism—SLC2A2—breast cancer	1.22e-05	0.000262	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—BRCA2—breast cancer	1.21e-05	0.00026	CbGpPWpGaD
Nelarabine—Chest pain—Methotrexate—breast cancer	1.21e-05	0.000153	CcSEcCtD
Nelarabine—Myalgia—Methotrexate—breast cancer	1.21e-05	0.000153	CcSEcCtD
Nelarabine—Arthralgia—Methotrexate—breast cancer	1.21e-05	0.000153	CcSEcCtD
Nelarabine—Vomiting—Paclitaxel—breast cancer	1.2e-05	0.000153	CcSEcCtD
Nelarabine—Dysgeusia—Doxorubicin—breast cancer	1.2e-05	0.000153	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.2e-05	0.000258	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTR—breast cancer	1.19e-05	0.000257	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CPT1A—breast cancer	1.19e-05	0.000257	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCG2—breast cancer	1.19e-05	0.000257	CbGpPWpGaD
Nelarabine—Leukopenia—Epirubicin—breast cancer	1.19e-05	0.000151	CcSEcCtD
Nelarabine—Back pain—Doxorubicin—breast cancer	1.19e-05	0.000151	CcSEcCtD
Nelarabine—Headache—Paclitaxel—breast cancer	1.19e-05	0.000151	CcSEcCtD
Nelarabine—DCK—Metabolism—DPYD—breast cancer	1.19e-05	0.000255	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MED12—breast cancer	1.19e-05	0.000255	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCNE1—breast cancer	1.17e-05	0.000252	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HPGDS—breast cancer	1.17e-05	0.000252	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.17e-05	0.000251	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALDOA—breast cancer	1.17e-05	0.000251	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—RB1—breast cancer	1.17e-05	0.000251	CbGpPWpGaD
Nelarabine—Confusional state—Methotrexate—breast cancer	1.17e-05	0.000148	CcSEcCtD
Nelarabine—Loss of consciousness—Epirubicin—breast cancer	1.17e-05	0.000148	CcSEcCtD
Nelarabine—ADA—Metabolism—HBA1—breast cancer	1.16e-05	0.000251	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—BIRC5—breast cancer	1.16e-05	0.000249	CbGpPWpGaD
Nelarabine—Cough—Epirubicin—breast cancer	1.16e-05	0.000147	CcSEcCtD
Nelarabine—Vision blurred—Doxorubicin—breast cancer	1.16e-05	0.000147	CcSEcCtD
Nelarabine—Asthenia—Docetaxel—breast cancer	1.15e-05	0.000146	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—TYMS—breast cancer	1.15e-05	0.000248	CbGpPWpGaD
Nelarabine—Convulsion—Epirubicin—breast cancer	1.15e-05	0.000146	CcSEcCtD
Nelarabine—Infection—Methotrexate—breast cancer	1.15e-05	0.000146	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—IL6—breast cancer	1.15e-05	0.000247	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTT1—breast cancer	1.14e-05	0.000245	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ACHE—breast cancer	1.14e-05	0.000245	CbGpPWpGaD
Nelarabine—Nervous system disorder—Methotrexate—breast cancer	1.13e-05	0.000144	CcSEcCtD
Nelarabine—Anaemia—Doxorubicin—breast cancer	1.13e-05	0.000144	CcSEcCtD
Nelarabine—DCK—Metabolism—NCOA3—breast cancer	1.13e-05	0.000244	CbGpPWpGaD
Nelarabine—Thrombocytopenia—Methotrexate—breast cancer	1.13e-05	0.000144	CcSEcCtD
Nelarabine—Arthralgia—Epirubicin—breast cancer	1.13e-05	0.000143	CcSEcCtD
Nelarabine—Chest pain—Epirubicin—breast cancer	1.13e-05	0.000143	CcSEcCtD
Nelarabine—Myalgia—Epirubicin—breast cancer	1.13e-05	0.000143	CcSEcCtD
Nelarabine—DCK—Metabolism—SLC2A2—breast cancer	1.13e-05	0.000242	CbGpPWpGaD
Nelarabine—Nausea—Paclitaxel—breast cancer	1.12e-05	0.000143	CcSEcCtD
Nelarabine—Asthenia—Capecitabine—breast cancer	1.11e-05	0.000141	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—H2AFX—breast cancer	1.11e-05	0.000239	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.1e-05	0.000238	CbGpPWpGaD
Nelarabine—Anorexia—Methotrexate—breast cancer	1.1e-05	0.00014	CcSEcCtD
Nelarabine—DCK—Metabolism—MTR—breast cancer	1.1e-05	0.000237	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCG2—breast cancer	1.1e-05	0.000237	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CPT1A—breast cancer	1.1e-05	0.000237	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—E2F1—breast cancer	1.1e-05	0.000237	CbGpPWpGaD
Nelarabine—Leukopenia—Doxorubicin—breast cancer	1.1e-05	0.000139	CcSEcCtD
Nelarabine—Diarrhoea—Docetaxel—breast cancer	1.1e-05	0.000139	CcSEcCtD
Nelarabine—Confusional state—Epirubicin—breast cancer	1.09e-05	0.000139	CcSEcCtD
Nelarabine—Oedema—Epirubicin—breast cancer	1.08e-05	0.000137	CcSEcCtD
Nelarabine—DCK—Metabolism—HPGDS—breast cancer	1.08e-05	0.000233	CbGpPWpGaD
Nelarabine—Hypotension—Methotrexate—breast cancer	1.08e-05	0.000137	CcSEcCtD
Nelarabine—Loss of consciousness—Doxorubicin—breast cancer	1.08e-05	0.000137	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP17A1—breast cancer	1.08e-05	0.000231	CbGpPWpGaD
Nelarabine—Infection—Epirubicin—breast cancer	1.08e-05	0.000136	CcSEcCtD
Nelarabine—DCK—Metabolism—HBA1—breast cancer	1.07e-05	0.000231	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.07e-05	0.000231	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTEN—breast cancer	1.07e-05	0.000231	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.07e-05	0.000231	CbGpPWpGaD
Nelarabine—Cough—Doxorubicin—breast cancer	1.07e-05	0.000136	CcSEcCtD
Nelarabine—ADA—Metabolism—ENO1—breast cancer	1.06e-05	0.000229	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS1—breast cancer	1.06e-05	0.000229	CbGpPWpGaD
Nelarabine—Convulsion—Doxorubicin—breast cancer	1.06e-05	0.000135	CcSEcCtD
Nelarabine—Diarrhoea—Capecitabine—breast cancer	1.06e-05	0.000135	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDK2—breast cancer	1.06e-05	0.000229	CbGpPWpGaD
Nelarabine—Nervous system disorder—Epirubicin—breast cancer	1.06e-05	0.000135	CcSEcCtD
Nelarabine—Dizziness—Docetaxel—breast cancer	1.06e-05	0.000135	CcSEcCtD
Nelarabine—Thrombocytopenia—Epirubicin—breast cancer	1.06e-05	0.000134	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Methotrexate—breast cancer	1.05e-05	0.000134	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.05e-05	0.000226	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ACHE—breast cancer	1.05e-05	0.000226	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTT1—breast cancer	1.05e-05	0.000226	CbGpPWpGaD
Nelarabine—Insomnia—Methotrexate—breast cancer	1.05e-05	0.000133	CcSEcCtD
Nelarabine—Myalgia—Doxorubicin—breast cancer	1.04e-05	0.000133	CcSEcCtD
Nelarabine—Chest pain—Doxorubicin—breast cancer	1.04e-05	0.000133	CcSEcCtD
Nelarabine—Arthralgia—Doxorubicin—breast cancer	1.04e-05	0.000133	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP2D6—breast cancer	1.04e-05	0.000225	CbGpPWpGaD
Nelarabine—Paraesthesia—Methotrexate—breast cancer	1.04e-05	0.000132	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—BIRC5—breast cancer	1.04e-05	0.000223	CbGpPWpGaD
Nelarabine—Anorexia—Epirubicin—breast cancer	1.03e-05	0.000131	CcSEcCtD
Nelarabine—Dyspnoea—Methotrexate—breast cancer	1.03e-05	0.000131	CcSEcCtD
Nelarabine—Somnolence—Methotrexate—breast cancer	1.03e-05	0.00013	CcSEcCtD
Nelarabine—Dizziness—Capecitabine—breast cancer	1.03e-05	0.00013	CcSEcCtD
Nelarabine—ADA—Metabolism—NCOA2—breast cancer	1.02e-05	0.000221	CbGpPWpGaD
Nelarabine—Vomiting—Docetaxel—breast cancer	1.02e-05	0.000129	CcSEcCtD
Nelarabine—Hypotension—Epirubicin—breast cancer	1.01e-05	0.000128	CcSEcCtD
Nelarabine—Confusional state—Doxorubicin—breast cancer	1.01e-05	0.000128	CcSEcCtD
Nelarabine—Decreased appetite—Methotrexate—breast cancer	1.01e-05	0.000128	CcSEcCtD
Nelarabine—Headache—Docetaxel—breast cancer	1.01e-05	0.000128	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDK4—breast cancer	1e-05	0.000216	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TERT—breast cancer	1e-05	0.000216	CbGpPWpGaD
Nelarabine—Oedema—Doxorubicin—breast cancer	1e-05	0.000127	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1e-05	0.000215	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Methotrexate—breast cancer	9.99e-06	0.000127	CcSEcCtD
Nelarabine—Fatigue—Methotrexate—breast cancer	9.97e-06	0.000127	CcSEcCtD
Nelarabine—Infection—Doxorubicin—breast cancer	9.95e-06	0.000126	CcSEcCtD
Nelarabine—ADA—Metabolism—FASN—breast cancer	9.94e-06	0.000214	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP17A1—breast cancer	9.93e-06	0.000214	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	9.93e-06	0.000214	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BCHE—breast cancer	9.9e-06	0.000213	CbGpPWpGaD
Nelarabine—Pain—Methotrexate—breast cancer	9.89e-06	0.000126	CcSEcCtD
Nelarabine—Vomiting—Capecitabine—breast cancer	9.88e-06	0.000125	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Epirubicin—breast cancer	9.86e-06	0.000125	CcSEcCtD
Nelarabine—DCK—Metabolism—PTGS1—breast cancer	9.83e-06	0.000211	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ENO1—breast cancer	9.83e-06	0.000211	CbGpPWpGaD
Nelarabine—Nervous system disorder—Doxorubicin—breast cancer	9.82e-06	0.000125	CcSEcCtD
Nelarabine—Thrombocytopenia—Doxorubicin—breast cancer	9.81e-06	0.000124	CcSEcCtD
Nelarabine—Insomnia—Epirubicin—breast cancer	9.79e-06	0.000124	CcSEcCtD
Nelarabine—ADA—Metabolism—SLC5A5—breast cancer	9.78e-06	0.00021	CbGpPWpGaD
Nelarabine—Headache—Capecitabine—breast cancer	9.73e-06	0.000124	CcSEcCtD
Nelarabine—Paraesthesia—Epirubicin—breast cancer	9.72e-06	0.000123	CcSEcCtD
Nelarabine—Dyspnoea—Epirubicin—breast cancer	9.65e-06	0.000122	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP2D6—breast cancer	9.64e-06	0.000207	CbGpPWpGaD
Nelarabine—Somnolence—Epirubicin—breast cancer	9.62e-06	0.000122	CcSEcCtD
Nelarabine—Anorexia—Doxorubicin—breast cancer	9.55e-06	0.000121	CcSEcCtD
Nelarabine—Nausea—Docetaxel—breast cancer	9.53e-06	0.000121	CcSEcCtD
Nelarabine—Feeling abnormal—Methotrexate—breast cancer	9.53e-06	0.000121	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CDK2—breast cancer	9.5e-06	0.000204	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Methotrexate—breast cancer	9.46e-06	0.00012	CcSEcCtD
Nelarabine—DCK—Metabolism—NCOA2—breast cancer	9.46e-06	0.000204	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NQO1—breast cancer	9.44e-06	0.000203	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC2A1—breast cancer	9.44e-06	0.000203	CbGpPWpGaD
Nelarabine—Decreased appetite—Epirubicin—breast cancer	9.41e-06	0.000119	CcSEcCtD
Nelarabine—Hypotension—Doxorubicin—breast cancer	9.36e-06	0.000119	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Epirubicin—breast cancer	9.35e-06	0.000119	CcSEcCtD
Nelarabine—Fatigue—Epirubicin—breast cancer	9.33e-06	0.000118	CcSEcCtD
Nelarabine—Constipation—Epirubicin—breast cancer	9.26e-06	0.000117	CcSEcCtD
Nelarabine—Pain—Epirubicin—breast cancer	9.26e-06	0.000117	CcSEcCtD
Nelarabine—Nausea—Capecitabine—breast cancer	9.23e-06	0.000117	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP3A4—breast cancer	9.21e-06	0.000198	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FASN—breast cancer	9.17e-06	0.000197	CbGpPWpGaD
Nelarabine—Abdominal pain—Methotrexate—breast cancer	9.14e-06	0.000116	CcSEcCtD
Nelarabine—Body temperature increased—Methotrexate—breast cancer	9.14e-06	0.000116	CcSEcCtD
Nelarabine—DCK—Metabolism—BCHE—breast cancer	9.14e-06	0.000197	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.13e-06	0.000116	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	9.12e-06	0.000196	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—ABCB1—breast cancer	9.11e-06	0.00365	CrCbGaD
Nelarabine—Insomnia—Doxorubicin—breast cancer	9.06e-06	0.000115	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP1B1—breast cancer	9.05e-06	0.000195	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC5A5—breast cancer	9.02e-06	0.000194	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—ATM—breast cancer	9.01e-06	0.000194	CbGpPWpGaD
Nelarabine—Paraesthesia—Doxorubicin—breast cancer	8.99e-06	0.000114	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CDK4—breast cancer	8.98e-06	0.000193	CbGpPWpGaD
Nelarabine—Dyspnoea—Doxorubicin—breast cancer	8.93e-06	0.000113	CcSEcCtD
Nelarabine—Feeling abnormal—Epirubicin—breast cancer	8.92e-06	0.000113	CcSEcCtD
Nelarabine—Somnolence—Doxorubicin—breast cancer	8.9e-06	0.000113	CcSEcCtD
Nelarabine—ADA—Metabolism—HSP90AA1—breast cancer	8.88e-06	0.000191	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Epirubicin—breast cancer	8.85e-06	0.000112	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	8.82e-06	0.00019	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—RB1—breast cancer	8.73e-06	0.000188	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC2A1—breast cancer	8.72e-06	0.000188	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NQO1—breast cancer	8.72e-06	0.000188	CbGpPWpGaD
Nelarabine—Decreased appetite—Doxorubicin—breast cancer	8.71e-06	0.00011	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Doxorubicin—breast cancer	8.65e-06	0.00011	CcSEcCtD
Nelarabine—ADA—Metabolism—NCOA1—breast cancer	8.64e-06	0.000186	CbGpPWpGaD
Nelarabine—Fatigue—Doxorubicin—breast cancer	8.64e-06	0.00011	CcSEcCtD
Nelarabine—Constipation—Doxorubicin—breast cancer	8.57e-06	0.000109	CcSEcCtD
Nelarabine—Pain—Doxorubicin—breast cancer	8.57e-06	0.000109	CcSEcCtD
Nelarabine—Body temperature increased—Epirubicin—breast cancer	8.56e-06	0.000109	CcSEcCtD
Nelarabine—Abdominal pain—Epirubicin—breast cancer	8.56e-06	0.000109	CcSEcCtD
Nelarabine—ADA—Metabolism—STK11—breast cancer	8.51e-06	0.000183	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP19A1—breast cancer	8.51e-06	0.000183	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP3A4—breast cancer	8.5e-06	0.000183	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP1B1—breast cancer	8.36e-06	0.00018	CbGpPWpGaD
Nelarabine—Asthenia—Methotrexate—breast cancer	8.3e-06	0.000105	CcSEcCtD
Nelarabine—Feeling abnormal—Doxorubicin—breast cancer	8.25e-06	0.000105	CcSEcCtD
Nelarabine—DCK—Metabolism—HSP90AA1—breast cancer	8.19e-06	0.000176	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Doxorubicin—breast cancer	8.19e-06	0.000104	CcSEcCtD
Nelarabine—DCK—Metabolism—NCOA1—breast cancer	7.97e-06	0.000172	CbGpPWpGaD
Nelarabine—Body temperature increased—Doxorubicin—breast cancer	7.92e-06	0.0001	CcSEcCtD
Nelarabine—Abdominal pain—Doxorubicin—breast cancer	7.92e-06	0.0001	CcSEcCtD
Nelarabine—Diarrhoea—Methotrexate—breast cancer	7.91e-06	0.0001	CcSEcCtD
Nelarabine—ADA—Metabolism—COMT—breast cancer	7.91e-06	0.00017	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTP1—breast cancer	7.88e-06	0.000169	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP19A1—breast cancer	7.86e-06	0.000169	CbGpPWpGaD
Nelarabine—DCK—Metabolism—STK11—breast cancer	7.86e-06	0.000169	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—RB1—breast cancer	7.81e-06	0.000168	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMOX1—breast cancer	7.77e-06	0.000167	CbGpPWpGaD
Nelarabine—Asthenia—Epirubicin—breast cancer	7.77e-06	9.86e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—ITPR1—breast cancer	7.75e-06	0.000167	CbGpPWpGaD
Nelarabine—Dizziness—Methotrexate—breast cancer	7.65e-06	9.71e-05	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CA—breast cancer	7.56e-06	0.000163	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCB1—breast cancer	7.46e-06	0.00016	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.45e-06	0.00016	CbGpPWpGaD
Nelarabine—Diarrhoea—Epirubicin—breast cancer	7.41e-06	9.4e-05	CcSEcCtD
Nelarabine—Vomiting—Methotrexate—breast cancer	7.36e-06	9.33e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—TYMS—breast cancer	7.32e-06	0.000158	CbGpPWpGaD
Nelarabine—DCK—Metabolism—COMT—breast cancer	7.3e-06	0.000157	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTP1—breast cancer	7.27e-06	0.000156	CbGpPWpGaD
Nelarabine—Headache—Methotrexate—breast cancer	7.25e-06	9.2e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—PLA2G4A—breast cancer	7.24e-06	0.000156	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NCOR1—breast cancer	7.24e-06	0.000156	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTM1—breast cancer	7.24e-06	0.000156	CbGpPWpGaD
Nelarabine—Asthenia—Doxorubicin—breast cancer	7.19e-06	9.12e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—HMOX1—breast cancer	7.17e-06	0.000154	CbGpPWpGaD
Nelarabine—Dizziness—Epirubicin—breast cancer	7.16e-06	9.08e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—ITPR1—breast cancer	7.15e-06	0.000154	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—breast cancer	7.15e-06	0.000154	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPX1—breast cancer	6.93e-06	0.000149	CbGpPWpGaD
Nelarabine—Vomiting—Epirubicin—breast cancer	6.88e-06	8.73e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—ABCB1—breast cancer	6.88e-06	0.000148	CbGpPWpGaD
Nelarabine—Nausea—Methotrexate—breast cancer	6.87e-06	8.72e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP1A1—breast cancer	6.86e-06	0.000148	CbGpPWpGaD
Nelarabine—Diarrhoea—Doxorubicin—breast cancer	6.85e-06	8.7e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—ERCC2—breast cancer	6.81e-06	0.000146	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—breast cancer	6.8e-06	0.000146	CbGpPWpGaD
Nelarabine—Headache—Epirubicin—breast cancer	6.78e-06	8.61e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—TYMS—breast cancer	6.76e-06	0.000145	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOR1—breast cancer	6.68e-06	0.000144	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTM1—breast cancer	6.68e-06	0.000144	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLA2G4A—breast cancer	6.68e-06	0.000144	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MDM2—breast cancer	6.65e-06	0.000143	CbGpPWpGaD
Nelarabine—Dizziness—Doxorubicin—breast cancer	6.62e-06	8.41e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND1—breast cancer	6.48e-06	0.00014	CbGpPWpGaD
Nelarabine—Nausea—Epirubicin—breast cancer	6.43e-06	8.16e-05	CcSEcCtD
Nelarabine—ADA—Metabolism—MTHFR—breast cancer	6.4e-06	0.000138	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPX1—breast cancer	6.4e-06	0.000138	CbGpPWpGaD
Nelarabine—Vomiting—Doxorubicin—breast cancer	6.37e-06	8.08e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP1A1—breast cancer	6.33e-06	0.000136	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ERCC2—breast cancer	6.28e-06	0.000135	CbGpPWpGaD
Nelarabine—Headache—Doxorubicin—breast cancer	6.28e-06	7.96e-05	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—breast cancer	6.27e-06	0.000135	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—breast cancer	6.18e-06	0.000133	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1B—breast cancer	6.08e-06	0.000131	CbGpPWpGaD
Nelarabine—Nausea—Doxorubicin—breast cancer	5.95e-06	7.55e-05	CcSEcCtD
Nelarabine—DCK—Metabolism—MTHFR—breast cancer	5.9e-06	0.000127	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAV1—breast cancer	5.9e-06	0.000127	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND1—breast cancer	5.8e-06	0.000125	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1A—breast cancer	5.61e-06	0.000121	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAV1—breast cancer	5.45e-06	0.000117	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CG—breast cancer	5.37e-06	0.000116	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MAPK3—breast cancer	5.35e-06	0.000115	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—breast cancer	5.2e-06	0.000112	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CG—breast cancer	4.96e-06	0.000107	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAPK3—breast cancer	4.78e-06	0.000103	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CD—breast cancer	4.72e-06	0.000102	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—breast cancer	4.66e-06	0.0001	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—breast cancer	4.65e-06	0.0001	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NOS3—breast cancer	4.46e-06	9.6e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CD—breast cancer	4.36e-06	9.38e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—breast cancer	4.3e-06	9.26e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CB—breast cancer	4.12e-06	8.86e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NOS3—breast cancer	4.12e-06	8.86e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—breast cancer	4.08e-06	8.78e-05	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—breast cancer	3.82e-06	8.22e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CB—breast cancer	3.8e-06	8.18e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—breast cancer	3.77e-06	8.1e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTEN—breast cancer	3.56e-06	7.66e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTEN—breast cancer	3.28e-06	7.07e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—breast cancer	2.51e-06	5.4e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—breast cancer	2.32e-06	4.99e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—breast cancer	2.05e-06	4.41e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—breast cancer	1.89e-06	4.07e-05	CbGpPWpGaD
